25 results
8-K
EX-10.1
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
), trade secret, innovation, trademark, data, database, or the like, whether or not patentable, together with all intellectual property rights therein
8-K
EX-10.2
7b09s9po1
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
xcgv d1jtn
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.3
wmdwpm315n32l22sujo
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
jpr9e0 87099obm6fi
17 Nov 23
Entry into a Material Definitive Agreement
5:03pm
8-K/A
EX-99.3
uqqo5s 3e4x
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
o7r59qwwp
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-10.1
vrh5w7a
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm
8-K
EX-10.1
atc55pi pv8u4
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
8-K
EX-10.1
xchrdscj4w sx
25 Sep 20
Diffusion Pharmaceuticals Strengthens Management Team with Appointmentof William Elder as General Counsel and Corporate Secretary
4:57pm
8-K
EX-10.2
54m0iqlek b2i4vezg
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am